Doxycycline post-exposure prophylaxis for preventing bacterial sexually transmitted infections (STIs): Are clinical providers supportive?

被引:1
作者
Imerlishvili, Esma [1 ,2 ]
Lake, John [1 ]
Todorovic, Sara [1 ]
Gonzalez, Charles [1 ,3 ]
Boos, Elizabeth M. [1 ,3 ]
Hart-Malloy, Rachel [1 ,3 ,4 ]
机构
[1] Hlth AIDS Inst, New York State Dept, Empire State Plaza,Corning Tower,Room 542, Albany, NY 12237 USA
[2] Partnership Res & Act Hlth, Tbilisi, Georgia
[3] SUNY Albany, Ctr Collaborat HIV Res Practice & Policy, Sch Publ Hlth, Albany, NY USA
[4] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Albany, NY USA
基金
美国国家卫生研究院;
关键词
Doxycycline prophylaxis; bacterial STIs; post-exposure prophylaxis; MEN; SEX;
D O I
10.1177/09564624241309433
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Bacterial sexually transmitted infections (STIs) continue to increase in the United States. Despite evidence of the effectiveness of doxycycline post-exposure prophylaxis (Doxy-PEP) to prevent STIs, little is known about providers' attitudes and willingness to implement Doxy-PEP.Methods An online questionnaire was sent to 575 clinical providers in New York State in September 2022.Results Ninety-one eligible individuals responded. Most providers served men who have sex with men (MSM) (84%); reported willingness to recommend Doxy-PEP (98%, 77%, and 67% for chlamydia, syphilis, and gonorrhea, respectively); preferred Doxy-PEP administration for MSM and transgender populations; believed recurring bacterial STIs (88%) and reported condomless sex (85%) were the most important characteristics to consider for recommending Doxy-PEP; and were concerned about antibiotic resistance (90%) (primarily for Neisseria gonorrhoeae). Insurance costs were the most perceived community-associated barriers (35%). There were no significant differences in providers' recommendations towards Doxy-PEP use when comparing clinicians' years of experience, regions, or professional titles.Conclusions Study results suggest high willingness and support for implementing Doxy-PEP. As this survey was administered prior to national guidelines on the use of Doxy-PEP, these data can be used as a baseline to compare to studies conducted after their release to formulate appropriate messages for providers to improve implementation.
引用
收藏
页码:297 / 303
页数:7
相关论文
共 50 条
[1]   Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa [J].
Peters, Remco P. H. ;
Mcintyre, James A. ;
Garrett, Nigel ;
Brink, Adrian J. ;
Celum, Connie L. ;
Bekker, Linda -Gail .
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023, 24 (01)
[2]   Potential Impact of Doxycycline Post-exposure Prophylaxis Prescribing Strategies on Incidence of Bacterial Sexually Transmitted Infections [J].
Traeger, Michael W. ;
Mayer, Kenneth H. ;
Krakower, Douglas S. ;
Gitin, Sy ;
Jenness, Samuel M. ;
Marcus, Julia L. .
CLINICAL INFECTIOUS DISEASES, 2023,
[3]   Early adopters of doxycycline as post-exposure prophylaxis to prevent bacterial sexually transmitted infections in a real-world clinical setting [J].
Chan, Philip A. ;
Malyuta, Yelena ;
Parent, Hannah ;
Tao, Jun ;
Erbe, Maximillian ;
Salhaney, Peter ;
Maynard, Michaela ;
DeWitt, William ;
Reisopoulos, Antonio ;
Nunn, Amy .
SEXUALLY TRANSMITTED INFECTIONS, 2024, 100 (06) :339-342
[4]   Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections [J].
Grant, Juliana S. ;
Stafylis, Chrysovalantis ;
Celum, Connie ;
Grennan, Troy ;
Haire, Bridget ;
Kaldor, John ;
Luetkemeyer, Anne F. ;
Saunders, John M. ;
Molina, Jean-Michel ;
Klausner, Jeffrey D. .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (06) :1247-1253
[5]   Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome [J].
Chu, Victoria T. ;
Glascock, Abigail ;
Donnell, Deborah ;
Grabow, Cole ;
Brown, Clare E. ;
Ward, Ryan ;
Love, Christina ;
Kalantar, Katrina L. ;
Cohen, Stephanie E. ;
Cannon, Chase ;
Woodworth, Michael H. ;
Kelley, Colleen F. ;
Celum, Connie ;
Luetkemeyer, Anne F. ;
Langelier, Charles R. .
NATURE MEDICINE, 2025, 31 (01) :207-217
[6]   Pre and post-exposure prophylaxis with doxycycline: Exploring promises for prevention of sexually transmitted infections in the Indian context [J].
Mehta, Hitaishi ;
Gupta, Manavi ;
Bishnoi, Anuradha ;
Vinay, Keshavamurthy .
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (05) :671-672
[7]   Doxycycline post-exposure prophylaxis (doxyPEP): balancing promise and prudence in the prevention of sexually transmitted infections [J].
Lyons, Fiona ;
Shanley, Adam .
EUROSURVEILLANCE, 2025, 30 (26)
[8]   Promises, Pitfalls, and Progress: Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections [J].
Kaperak, Christopher J. ;
Flores, John M. ;
Hazra, Aniruddha .
CURRENT HIV/AIDS REPORTS, 2025, 22 (01)
[9]   Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections [J].
Hazra, Aniruddha ;
Mcnulty, Moira C. ;
Pyra, Maria ;
Pagkas-Bather, Jade ;
Gutierrez, Jose, I ;
Pickett, Jim ;
Stewart, Jenell ;
Bolan, Robert K. ;
Molina, Jean-Michel ;
Celum, Connie ;
Luetkemeyer, Anne F. ;
Klausner, Jeffrey D. .
CLINICAL INFECTIOUS DISEASES, 2024,
[10]   Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and Perils [J].
Siguier, Martin ;
Molina, Jean-Michel .
ACS INFECTIOUS DISEASES, 2018, 4 (05) :660-663